OTC Markets OTCQB - Delayed Quote USD

Willow Biosciences Inc. (CANSF)

0.0260
0.0000
(0.00%)
At close: May 19 at 4:00:00 PM EDT
Loading Chart for CANSF
  • Previous Close 0.0000
  • Open 0.0264
  • Bid 0.0200 x --
  • Ask 0.0257 x --
  • Day's Range 0.0200 - 0.0264
  • 52 Week Range 0.0030 - 0.1000
  • Volume 686,000
  • Avg. Volume 63,563
  • Market Cap (intraday) 3.766M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

www.willowbio.com

19

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CANSF

View More

Performance Overview: CANSF

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CANSF
36.59%
S&P/TSX Composite index (^GSPTSE)
5.49%

1-Year Return

CANSF
58.73%
S&P/TSX Composite index (^GSPTSE)
15.61%

3-Year Return

CANSF
80.45%
S&P/TSX Composite index (^GSPTSE)
28.69%

5-Year Return

CANSF
96.99%
S&P/TSX Composite index (^GSPTSE)
74.48%

Compare To: CANSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CANSF

View More

Valuation Measures

Annual
As of 5/19/2025
  • Market Cap

    3.11M

  • Enterprise Value

    4.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.06

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CANSF

View More

Company Insights: CANSF

Research Reports: CANSF

View More

People Also Watch